| 2024-02-12 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 1,148 0.001% | $67.77 | $77,796 | -27.14% | |
| 2024-01-29 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 906 0.0008% | $64.14 | $58,109 | -19.54% | |
| 2024-01-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 3,413 0.0029% | $65.00 | $221,831 | -15.29% | |
| 2024-01-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 2,235 0.0019% | $66.81 | $149,317 | -16.92% | |
| 2023-12-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 110,000 0.0931% | $60.81 | $6.69M | -6.26% | |
| 2023-05-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0043% | $82.71 | $413,550 | -33.85% | |
| 2023-04-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0042% | $74.05 | $370,250 | -20.87% | |
| 2023-03-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0043% | $63.84 | $319,200 | -2.97% | |
| 2023-02-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0045% | $55.85 | $279,250 | +13.38% | |
| 2023-01-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0044% | $50.70 | $253,500 | +8.59% | |
| 2022-12-05 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0047% | $50.38 | $251,900 | +5.76% | |
| 2022-11-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0045% | $58.54 | $292,700 | -13.47% | |
| 2022-10-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.005% | $66.69 | $333,450 | ||
| 2022-09-06 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0048% | $60.38 | $301,900 | +2.13% | |
| 2022-08-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 12,500 0.0115% | $69.00 | $862,500 | -11.35% | |
| 2022-08-11 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 25,000 0.0234% | $67.00 | $1.68M | -6.65% | |
| 2022-08-08 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 25,000 0.0239% | $65.00 | $1.63M | -0.64% | |
| 2022-08-03 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 10,000 0.0089% | $56.43 | $564,300 | +7.59% | |
| 2022-07-11 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0048% | $48.42 | $242,100 | +31.38% | |
| 2022-04-21 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Commercial Officer | 5,000 0.0045% | $48.42 | $242,100 | +3.91% |